These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34442810)

  • 21. A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life.
    Duan Q; Xia S; Jiao F; Wang Q; Wang R; Lu L; Jiang S; Xu W
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks.
    Schneider WM; Luna JM; Hoffmann HH; Sánchez-Rivera FJ; Leal AA; Ashbrook AW; Le Pen J; Michailidis E; Ricardo-Lax I; Peace A; Stenzel AF; Lowe SW; MacDonald MR; Rice CM; Poirier JT
    bioRxiv; 2020 Oct; ():. PubMed ID: 33052332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
    Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
    Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved plaque assay for human coronaviruses 229E and OC43.
    Bracci N; Pan HC; Lehman C; Kehn-Hall K; Lin SC
    PeerJ; 2020; 8():e10639. PubMed ID: 33391888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surveillance of Bat Coronaviruses in Kenya Identifies Relatives of Human Coronaviruses NL63 and 229E and Their Recombination History.
    Tao Y; Shi M; Chommanard C; Queen K; Zhang J; Markotter W; Kuzmin IV; Holmes EC; Tong S
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28077633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.
    Hoffmann HH; Schneider WM; Sánchez-Rivera FJ; Luna JM; Ashbrook AW; Soto-Feliciano YM; Leal AA; Le Pen J; Ricardo-Lax I; Michailidis E; Hao Y; Stenzel AF; Peace A; Allis CD; Lowe SW; MacDonald MR; Poirier JT; Rice CM
    bioRxiv; 2020 Sep; ():. PubMed ID: 32935098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor.
    LeBlanc EV; Colpitts CC
    Sci Rep; 2022 Jul; 12(1):12899. PubMed ID: 35902713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
    Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
    J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
    Sheahan TP; Sims AC; Graham RL; Menachery VD; Gralinski LE; Case JB; Leist SR; Pyrc K; Feng JY; Trantcheva I; Bannister R; Park Y; Babusis D; Clarke MO; Mackman RL; Spahn JE; Palmiotti CA; Siegel D; Ray AS; Cihlar T; Jordan R; Denison MR; Baric RS
    Sci Transl Med; 2017 Jun; 9(396):. PubMed ID: 28659436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
    Qin S; Xia X; Shi X; Ji X; Ma F; Chen L
    Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
    Tamminen K; Salminen M; Blazevic V
    Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses.
    Cueno ME; Imai K
    Front Med (Lausanne); 2020; 7():594439. PubMed ID: 33585502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic promises of Lianhuaqingke in the mice model of coronavirus pneumonia (HCoV-229E and SARS-CoV-2).
    Wang M; Li W; Cui W; Hao Y; Mi Y; Wang H; Hou Y; Jia Z
    Chin Med; 2021 Oct; 16(1):104. PubMed ID: 34663385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperforin, the major metabolite of St. John's wort, exhibits pan-coronavirus antiviral activity.
    Raczkiewicz I; Rivière C; Bouquet P; Desmarets L; Tarricone A; Camuzet C; François N; Lefèvre G; Silva Angulo F; Robil C; Trottein F; Sahpaz S; Dubuisson J; Belouzard S; Goffard A; Séron K
    Front Microbiol; 2024; 15():1443183. PubMed ID: 39176276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.
    Raoult D; Zumla A; Locatelli F; Ippolito G; Kroemer G
    Cell Stress; 2020 Mar; 4(4):66-75. PubMed ID: 32292881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity.
    Mori M; Quaglio D; Calcaterra A; Ghirga F; Sorrentino L; Cammarone S; Fracella M; D'Auria A; Frasca F; Criscuolo E; Clementi N; Mancini N; Botta B; Antonelli G; Pierangeli A; Scagnolari C
    Microorganisms; 2023 Jan; 11(2):. PubMed ID: 36838279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives.
    Zhang L; Zhang J; Wang J; Ren C; Tang P; Ouyang L; Wang Y
    Eur J Med Chem; 2022 Mar; 232():114176. PubMed ID: 35151222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Replication Inhibitory Activity of Xanthorrhizol against Severe Acute Respiratory Syndrome Coronavirus 2.
    Kim M; Cho H; Ahn DG; Jung HG; Seo HY; Kim JS; Lee YJ; Choi JY; Park IH; Shin JS; Kim SJ; Oh JW
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.